Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
INBX · NASDAQ · Biological Products, (No Diagnostic Substances)
$68.97−5.36 (−7.21%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Inhibrx Biosciences (INBX) · oqro.io/stocks/INBX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Viking Global disclosed a reduced position in INBX for Q3 2026Source5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 28, 2026
BANK OF AMERICA CORP /DE/ cut its INBX stake below 5% (2.4%)SourceInsider trade · Traded Oct 14, 2026 · Filed Oct 14, 2026
CEO purchased ~$208K of INBX shares in the open marketSourceInsider trade · Traded Oct 14, 2026 · Filed Oct 14, 2026
CEO purchased ~$206K of INBX shares in the open marketSourceInsider trade · Traded Oct 14, 2026 · Filed Oct 14, 2026
CEO purchased ~$210K of INBX shares in the open marketSourceInsider trade · Traded Oct 14, 2026 · Filed Oct 14, 2026
CEO purchased ~$208K of INBX shares in the open marketSourceInsider trade · Traded Oct 14, 2026 · Filed Oct 14, 2026
CEO purchased ~$8.6K of INBX shares in the open marketSourceInsider trade · Traded Oct 14, 2026 · Filed Oct 14, 2026
CEO purchased ~$8.6K of INBX shares in the open marketSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 28, 2026
CEO purchased ~$329K of INBX shares in the open marketSourceInsider trade · Traded Sep 25, 2026 · Filed Sep 28, 2026
CEO purchased ~$217K of INBX shares in the open marketSourceInsider trade · Traded Sep 28, 2026 · Filed Sep 28, 2026
CEO purchased ~$305K of INBX shares in the open marketSourceInsider trade · Traded Sep 28, 2026 · Filed Sep 28, 2026
CEO purchased ~$148K of INBX shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a reduced position in INBX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global disclosed a reduced position in INBX for Q2 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Viking Global disclosed a reduced position in INBX for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed an increased position in INBX for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Perceptive Advisors LLC disclosed an increased position in INBX for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a reduced position in INBX for Q2 2025SourceInsider trade · Traded Nov 19, 2024 · Filed Nov 22, 2024
Director purchased ~$496K of INBX shares in the open marketSourceInsider trade · Traded Nov 19, 2024 · Filed Nov 22, 2024
Director purchased ~$496K of INBX shares in the open marketSourceInsider trade · Traded Nov 20, 2024 · Filed Nov 22, 2024
Director purchased ~$266K of INBX shares in the open marketSourceInsider trade · Traded Nov 20, 2024 · Filed Nov 22, 2024
Director purchased ~$266K of INBX shares in the open marketSourceInsider trade · Traded Oct 3, 2024 · Filed Oct 7, 2024
Director purchased ~$100K of INBX shares in the open marketSourceInsider trade · Traded Sep 23, 2026 · Filed Sep 23, 2026
Director purchased ~$500K of INBX shares in the open marketSource